An automated pipeline for quantitative T2* fetal body MRI and segmentation at low field.

Fetal Magnetic Resonance Imaging at low field strengths is emerging as an exciting direction in perinatal health. Clinical low field (0.55T) scanners are beneficial for fetal imaging due to their reduced susceptibility-induced artefacts, increased T2* values, and wider bore (widening access for the increasingly obese pregnant population). However, the lack of standard automated image processing tools such as segmentation and reconstruction hampers wider clinical use. In this study, we introduce a semi-automatic pipeline using quantitative MRI for the fetal body at low field strength resulting in fast and detailed quantitative T2* relaxometry analysis of all major fetal body organs. Multi-echo dynamic sequences of the fetal body were acquired and reconstructed into a single high-resolution volume using deformable slice-to-volume reconstruction, generating both structural and quantitative T2* 3D volumes. A neural network trained using a semi-supervised approach was created to automatically segment these fetal body 3D volumes into ten different organs (resulting in dice values > 0.74 for 8 out of 10 organs). The T2* values revealed a strong relationship with GA in the lungs, liver, and kidney parenchyma (R2 >0.5). This pipeline was used successfully for a wide range of GAs (17-40 weeks), and is robust to motion artefacts. Low field fetal MRI can be used to perform advanced MRI analysis, and is a viable option for clinical scanning.

Low-Field Combined Diffusion-Relaxation MRI for Mapping Placenta Structure and Function.

Purpose: Demonstrating quantitative multi-parametric mapping in the placenta with combined T2∗-diffusion MRI at low-field (0.55T). Methods: We present 57 placental MRI scans performed on a commercially available 0.55T scanner. We acquired the images using a combined T2∗-diffusion technique scan that simultaneously acquires multiple diffusion preparations and echo times. We processed the data to produce quantitative T2∗ and diffusivity maps using a combined T2∗-ADC model. We compared the derived quantitative parameters across gestation in healthy controls and a cohort of clinical cases. Results: Quantitative parameter maps closely resemble those from previous experiments at higher field strength, with similar trends in T2∗ and ADC against gestational age observed. Conclusion: Combined T2∗-diffusion placental MRI is reliably achievable at 0.55T. The advantages of lower field strength - such as cost, ease of deployment, increased accessibility and patient comfort due to the wider bore, and increased T2∗ for larger dynamic ranges - can support the widespread roll out of placental MRI as an adjunct to ultrasound during pregnancy.